Matches in SemOpenAlex for { <https://semopenalex.org/work/W2089163359> ?p ?o ?g. }
- W2089163359 endingPage "258" @default.
- W2089163359 startingPage "251" @default.
- W2089163359 abstract "The efficacy of flunixin alone and together with enrofloxacin in treatment of experimental Escherichia coli mastitis was compared using six cows. The cross-over study design was used. Pharmacokinetics of flunixin and enrofloxacin were also studied in these diseased cows. The response of each cow was similar after the first and second challenge and the individual reaction seemed to explain the severity of clinical signs. The most important predictive factor for outcome of E. coli mastitis was a heavy drop in milk yield. Treatment with enrofloxacin and flunixin enhanced elimination of bacteria, but the difference from those receiving flunixin alone was not significant. Two cows, which had received no antimicrobial treatment (Group 1), were killed on day 4 postchallenge. One cow was killed after the first and the other after the second challenge. Cows receiving combination therapy produced 0.9 L more milk per day during the study period than cows which had only received flunixin (P < 0.05). Based on our findings, antimicrobial treatment might be beneficial in the treatment of high-yielding cows in early lactation. The absorption of enrofloxacin was delayed after subcutaneous administration, the mean apparent elimination half-life being about 23 h, whereas after i.v. administration elimination t(1/2) was only 1.5 h. The majority of the antimicrobial activity in milk originated from the active metabolite, ciprofloxacin, which could be measured throughout the 120-h follow-up period after the last subcutaneous administration. No differences were present in the pharmacokinetic parameters of flunixin between treatment groups: mean elimination half-life was 5.7-6.2 h, volume of distribution 0.43-0.49 L/kg and clearance 0.13-0.14 L h/kg. No flunixin or merely traces were detected in milk: one of the three cows had a concentration of 0.019 mg/L 8 h after administration." @default.
- W2089163359 created "2016-06-24" @default.
- W2089163359 creator A5016323870 @default.
- W2089163359 creator A5026337288 @default.
- W2089163359 creator A5036214657 @default.
- W2089163359 creator A5041685785 @default.
- W2089163359 creator A5051479835 @default.
- W2089163359 creator A5056246575 @default.
- W2089163359 creator A5058695162 @default.
- W2089163359 creator A5066193960 @default.
- W2089163359 date "2002-08-01" @default.
- W2089163359 modified "2023-10-17" @default.
- W2089163359 title "Efficacy and pharmacokinetics of enrofloxacin and flunixin meglumine for treatment of cows with experimentally induced Escherichia coli mastitis" @default.
- W2089163359 cites W1491580460 @default.
- W2089163359 cites W15640077 @default.
- W2089163359 cites W164586581 @default.
- W2089163359 cites W1969275369 @default.
- W2089163359 cites W1972971151 @default.
- W2089163359 cites W1973279862 @default.
- W2089163359 cites W1981279375 @default.
- W2089163359 cites W1995821982 @default.
- W2089163359 cites W1997260229 @default.
- W2089163359 cites W2012554559 @default.
- W2089163359 cites W2045633848 @default.
- W2089163359 cites W2048638452 @default.
- W2089163359 cites W2056660811 @default.
- W2089163359 cites W2059545303 @default.
- W2089163359 cites W2082255018 @default.
- W2089163359 cites W2085795892 @default.
- W2089163359 cites W2086584950 @default.
- W2089163359 cites W2094054189 @default.
- W2089163359 cites W2109367785 @default.
- W2089163359 cites W2111241613 @default.
- W2089163359 cites W2131261415 @default.
- W2089163359 cites W2144798275 @default.
- W2089163359 cites W2155575617 @default.
- W2089163359 cites W2161063835 @default.
- W2089163359 cites W2461984620 @default.
- W2089163359 cites W2904712726 @default.
- W2089163359 doi "https://doi.org/10.1046/j.1365-2885.2002.00411.x" @default.
- W2089163359 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12213112" @default.
- W2089163359 hasPublicationYear "2002" @default.
- W2089163359 type Work @default.
- W2089163359 sameAs 2089163359 @default.
- W2089163359 citedByCount "76" @default.
- W2089163359 countsByYear W20891633592012 @default.
- W2089163359 countsByYear W20891633592013 @default.
- W2089163359 countsByYear W20891633592014 @default.
- W2089163359 countsByYear W20891633592015 @default.
- W2089163359 countsByYear W20891633592016 @default.
- W2089163359 countsByYear W20891633592017 @default.
- W2089163359 countsByYear W20891633592018 @default.
- W2089163359 countsByYear W20891633592019 @default.
- W2089163359 countsByYear W20891633592022 @default.
- W2089163359 countsByYear W20891633592023 @default.
- W2089163359 crossrefType "journal-article" @default.
- W2089163359 hasAuthorship W2089163359A5016323870 @default.
- W2089163359 hasAuthorship W2089163359A5026337288 @default.
- W2089163359 hasAuthorship W2089163359A5036214657 @default.
- W2089163359 hasAuthorship W2089163359A5041685785 @default.
- W2089163359 hasAuthorship W2089163359A5051479835 @default.
- W2089163359 hasAuthorship W2089163359A5056246575 @default.
- W2089163359 hasAuthorship W2089163359A5058695162 @default.
- W2089163359 hasAuthorship W2089163359A5066193960 @default.
- W2089163359 hasConcept C104317684 @default.
- W2089163359 hasConcept C112705442 @default.
- W2089163359 hasConcept C140793950 @default.
- W2089163359 hasConcept C142724271 @default.
- W2089163359 hasConcept C178790620 @default.
- W2089163359 hasConcept C185592680 @default.
- W2089163359 hasConcept C2776344049 @default.
- W2089163359 hasConcept C2778512257 @default.
- W2089163359 hasConcept C2779906673 @default.
- W2089163359 hasConcept C4937899 @default.
- W2089163359 hasConcept C501593827 @default.
- W2089163359 hasConcept C547475151 @default.
- W2089163359 hasConcept C55493867 @default.
- W2089163359 hasConcept C71924100 @default.
- W2089163359 hasConcept C86803240 @default.
- W2089163359 hasConcept C98274493 @default.
- W2089163359 hasConceptScore W2089163359C104317684 @default.
- W2089163359 hasConceptScore W2089163359C112705442 @default.
- W2089163359 hasConceptScore W2089163359C140793950 @default.
- W2089163359 hasConceptScore W2089163359C142724271 @default.
- W2089163359 hasConceptScore W2089163359C178790620 @default.
- W2089163359 hasConceptScore W2089163359C185592680 @default.
- W2089163359 hasConceptScore W2089163359C2776344049 @default.
- W2089163359 hasConceptScore W2089163359C2778512257 @default.
- W2089163359 hasConceptScore W2089163359C2779906673 @default.
- W2089163359 hasConceptScore W2089163359C4937899 @default.
- W2089163359 hasConceptScore W2089163359C501593827 @default.
- W2089163359 hasConceptScore W2089163359C547475151 @default.
- W2089163359 hasConceptScore W2089163359C55493867 @default.
- W2089163359 hasConceptScore W2089163359C71924100 @default.
- W2089163359 hasConceptScore W2089163359C86803240 @default.
- W2089163359 hasConceptScore W2089163359C98274493 @default.
- W2089163359 hasIssue "4" @default.
- W2089163359 hasLocation W20891633591 @default.